Waiting
로그인 처리 중...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / Hochdurchsatz-In-vitro-Assay mit…
JoVE Journal
Cancer Research

이 콘텐츠 오픈 액세스로 구독없이 시청하실 수 있습니다.

JoVE Journal Cancer Research
Hochdurchsatz-In-vitro-Assay mit patientenabgeleiteten Tumororganoiden
In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Journal (Cancer Research)
In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Microinjection of DNA Plasmid Mix into the Mouse Brain Ventricle (Video) | JoVE
Journal (Cancer Research)
Microinjection of DNA Plasmid Mix into the Mouse Brain Ventricle (Video) | JoVE
 
Click here for the English version

Hochdurchsatz-In-vitro-Assay mit patientenabgeleiteten Tumororganoiden

Article DOI: 10.3791/62668-v • 06:25 min • June 14th, 2021
June 14th, 2021 •
1, 2,3, 2, 2, 2, 3, 2, 2
1FUJIFILM Wako Bio Solutions Corporation, 2Medical-Industrial Translational Research Center, Fukushima Medical University, 3Department of Bioregulation and Pharmacological Medicine, Fukushima Medical University

챕터

요약
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Ein hochgenaues In-vitro-Hochdurchsatz-Assay-System wurde entwickelt, um Krebsmedikamente unter Verwendung von von Patienten abgeleiteten Tumororganoiden (PDOs) zu bewerten, ähnlich wie Krebsgewebe, aber für In-vitro-Hochdurchsatz-Assay-Systeme mit 96-Well- und 384-Well-Platten ungeeignet sind.

Tags

Cancer Research Patient-derived tumor organoids cancer models anticancer agents molecular targeted drugs antibody drug cancer immunotherapy antibody-dependent cellular cytotoxicity high-throughput in vitro assay impedance-based cell analyzer
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter